These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 30772069)

  • 21. Impact of Haemophilus influenzae type b conjugate vaccine on bacterial meningitis in the Dominican Republic.
    Lee EH; Corcino M; Moore A; Garib Z; Peña C; Sánchez J; Fernández J; Feris-Iglesias JM; Flannery B
    Rev Panam Salud Publica; 2008 Sep; 24(3):161-8. PubMed ID: 19115543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Haemophilus influenzae type b (Hib) vaccine: an effective control strategy in India.
    Verma R; Khanna P; Chawla S; Bairwa M; Prinja S; Rajput M
    Hum Vaccin; 2011 Nov; 7(11):1158-60. PubMed ID: 22048118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of Haemophilus influenzae type b disease in The Gambia 14 years after introduction of routine Haemophilus influenzae type b conjugate vaccine immunization.
    Oluwalana C; Howie SR; Secka O; Ideh RC; Ebruke B; Sambou S; Erskine J; Lowe Y; Corrah T; Adegbola RA
    J Pediatr; 2013 Jul; 163(1 Suppl):S4-7. PubMed ID: 23773593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants.
    Mulholland K; Hilton S; Adegbola R; Usen S; Oparaugo A; Omosigho C; Weber M; Palmer A; Schneider G; Jobe K; Lahai G; Jaffar S; Secka O; Lin K; Ethevenaux C; Greenwood B
    Lancet; 1997 Apr; 349(9060):1191-7. PubMed ID: 9130939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study.
    Adegbola RA; Secka O; Lahai G; Lloyd-Evans N; Njie A; Usen S; Oluwalana C; Obaro S; Weber M; Corrah T; Mulholland K; McAdam K; Greenwood B; Milligan PJ
    Lancet; 2005 Jul 9-15; 366(9480):144-50. PubMed ID: 16005337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of Haemophilus influenzae type b Conjugate vaccine introduction into routine childhood immunization in Kenya.
    Cowgill KD; Ndiritu M; Nyiro J; Slack MP; Chiphatsi S; Ismail A; Kamau T; Mwangi I; English M; Newton CR; Feikin DR; Scott JA
    JAMA; 2006 Aug; 296(6):671-8. PubMed ID: 16896110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haemophilus influenzae type b conjugate vaccine is highly effective in the Ugandan routine immunization program: a case-control study.
    Lee EH; Lewis RF; Makumbi I; Kekitiinwa A; Ediamu TD; Bazibu M; Braka F; Flannery B; Zuber PL; Feikin DR
    Trop Med Int Health; 2008 Apr; 13(4):495-502. PubMed ID: 18312475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Childhood very severe pneumonia and meningitis-related hospitalization and death in Yemen, before and after introduction of H. influenzae type b (Hib) vaccine.
    Banajeh SM; Ashoor O; Al-Magramy AS
    East Mediterr Health J; 2014 Jul; 20(7):431-41. PubMed ID: 25023770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom.
    Heath PT; Booy R; Azzopardi HJ; Slack MP; Bowen-Morris J; Griffiths H; Ramsay ME; Deeks JJ; Moxon ER
    JAMA; 2000 Nov; 284(18):2334-40. PubMed ID: 11066183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-type b Haemophilus influenzae disease: clinical and epidemiologic characteristics in the Haemophilus influenzae type b vaccine era.
    Heath PT; Booy R; Azzopardi HJ; Slack MP; Fogarty J; Moloney AC; Ramsay ME; Moxon ER
    Pediatr Infect Dis J; 2001 Mar; 20(3):300-5. PubMed ID: 11303834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Community effect of Haemophilus influenzae type b vaccination in India.
    Verghese VP; Friberg IK; Cherian T; Raghupathy P; Balaji V; Lalitha MK; Thomas K; John TJ; Steinhoff MC
    Pediatr Infect Dis J; 2009 Aug; 28(8):738-40. PubMed ID: 19633518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Haemophilus influenzae type b vaccination without a booster dose on invasive H influenzae type b disease, nasopharyngeal carriage, and population immunity in Kilifi, Kenya: a 15-year regional surveillance study.
    Hammitt LL; Crane RJ; Karani A; Mutuku A; Morpeth SC; Burbidge P; Goldblatt D; Kamau T; Sharif S; Mturi N; Scott JA
    Lancet Glob Health; 2016 Mar; 4(3):e185-94. PubMed ID: 26853149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of introduction of the Haemophilus influenzae type b conjugate vaccine into childhood immunization on meningitis in Bangladeshi infants.
    Sultana NK; Saha SK; Al-Emran HM; Modak JK; Sharker MA; El-Arifeen S; Cohen AL; Baqui AH; Luby SP
    J Pediatr; 2013 Jul; 163(1 Suppl):S73-8. PubMed ID: 23773597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective multi-centre sentinel surveillance for Haemophilus influenzae type b & other bacterial meningitis in Indian children.
    Ramachandran P; Fitzwater SP; Aneja S; Verghese VP; Kumar V; Nedunchelian K; Wadhwa N; Veeraraghavan B; Kumar R; Meeran M; Kapil A; Jasmine S; Kumar A; Suresh S; Bhatnagar S; Thomas K; Awasthi S; Santosham M; Chandran A
    Indian J Med Res; 2013 Apr; 137(4):712-20. PubMed ID: 23703338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Haemophilus influenzae type b conjugate vaccination on hospitalization for invasive disease in children fifteen years after its introduction in Italy.
    Martinelli D; Azzari C; Bonanni P; Esposito S; Franco E; Icardi G; Zuccotti G; Prato R
    Vaccine; 2017 Nov; 35(46):6297-6301. PubMed ID: 28988865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A nationwide prospective surveillance study in Israel to document pediatric invasive infections, with an emphasis on Haemophilus influenzae type b infections. Israeli Pediatric Bacteremia and Meningitis Group.
    Dagan R; Fraser D; Greif Z; Keller N; Kaufstein M; Shazberg G; Schlesinger M
    Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S198-203. PubMed ID: 9781763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occurrence of Haemophilus influenzae strains in three Brazilian states since the introduction of a conjugate Haemophilus influenzae type b vaccine.
    de Almeida AE; de Filippis I; Abreu AO; Ferreira DG; Gemal AL; Marzochi KB
    Braz J Med Biol Res; 2005 May; 38(5):777-81. PubMed ID: 15917960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-polyribosylribitol phosphate antibody in pediatric patients with Haemophilus influenzae type b invasive disease.
    Ishiwada N; Honda Y; Tanaka J; Hishiki H; Kohno Y
    J Infect Chemother; 2011 Jun; 17(3):397-400. PubMed ID: 21188446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and immunogenocity of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C-tetanus-toxoid conjugate vaccine in healthy Chinese children aged 6 months to 5 years old.
    Hu JL; Tao H; Li JX; Dai WM; Song B; Sun JF; Liu P; Tang J; Liu WY; Wang SY; Zhu FC
    Hum Vaccin Immunother; 2015; 11(5):1120-8. PubMed ID: 25833163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccine-preventable haemophilus influenza type B disease burden and cost-effectiveness of infant vaccination in Indonesia.
    Gessner BD; Sedyaningsih ER; Griffiths UK; Sutanto A; Linehan M; Mercer D; Mulholland EK; Walker DG; Steinhoff M; Nadjib M
    Pediatr Infect Dis J; 2008 May; 27(5):438-43. PubMed ID: 18398383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.